NATULAN caps 50 mg 50 pce

7680584740023 CH-58474 L01XB01 07.16.1.

Reimbursement limitations:

NATULAN

Pour la thérapie de la maladie de Hodgkin et des lymphomes non-hodgkinien.

NATULAN caps 50 mg 50 pce
NATULAN caps 50 mg 50 pce
NATULAN caps 50 mg 50 pce
1 / 3
google

Details

Product number
5847401
CPT
-
Packaging group
50
Unit
Kapsel(n)
Composition
procarbazinum 50 mg ut procarbazini hydrochloridum, mannitolum, talcum, maydis amylum, magnesii stearas, materiale di capsula: gelatina, E 171, E 172 (flavum), pro capsula.

Articles (1)

Natulan, capsule rigide
Kapseln
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/10/2023
Patient information leaflet
Français
09/10/2023
Patient information leaflet
Italien
09/10/2023
Professional SmPC
Allemand
09/10/2023
Professional SmPC
Français
09/10/2023
Professional SmPC
Italien
09/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 279.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2008

Authorization holder

CD PHARMA (SUISSE) SA

6816 Bissone

Authorization information

Swissmedic authorization number
58474
Drug name
Natulan, capsule rigide
Galenic form
KAHA
ATC Code
L01XB01
Authorization status
Z
Dispensation category
A
First authorization
07/11/2008
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zur Kombinationschemotherapie bei Morbus Hodgkin; zur Kombinationschemotherapie bei Non-Hodgkin-Lymphomen

Packaging details

Description (FR)
NATULAN caps 50 mg 50 pce
Description (DE)
NATULAN Kaps 50 mg 50 Stk
Market launch
07/11/2008
Narcotic (BTM)
No

Other packaging sizes